Victory Capital Management
SCPH

Victory Capital Management’s scPharmaceuticals SCPH Stock Holding History

Victory Capital Management’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,710
Closed -$20K – 3152
2020
Q1 		$20K Buy
+2,710
New +$19.7K ﹤0.01% 2844
2019
Q4 		– Sell
-1,806
Closed -$11K – 3168
2019
Q3 		$11K Buy
+1,806
New +$10.2K ﹤0.01% 3234

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Victory Capital Management's SCPH Position: Q2 2020 in Review

Victory Capital Management sold out of scPharmaceuticals (SCPH) in Q2 2020, closing a stake of 2,710 shares — an estimated $20K sold.

Victory Capital Management first reported a position in SCPH in Q3 2019 and held it in 2 quarters. The position peaked at $20K in Q1 2020. 51 funds tracked by Wall St. Rank hold SCPH as of Q2 2020.

  • Victory Capital Management reported no remaining scPharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 2,710 scPharmaceuticals shares in Q2 2020, an estimated $20K.
  • Victory Capital Management first reported a position in scPharmaceuticals in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's scPharmaceuticals position peaked at $20K in Q1 2020.
  • 51 funds tracked by Wall St. Rank held scPharmaceuticals as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.